symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
DRTS,3.8,0.933001,65760,263994360,0,2.75-5.95,0.02,Alpha Tau Medical Ltd.,USD,0001871321,,M0740A108,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.alphatau.com,"Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.",Mr. Uzi  Sofer,Healthcare,IL,94,972 3 577 4115,5 Kiryat Hamada Street,Jerusalem,,9777605,,0,https://financialmodelingprep.com/image-stock/DRTS.png,2021-03-08,False,False,True,False,False
